Seegene, Inc. engages in the manufacture and distribution of molecular diagnostics and reagents. Its diagnostic services include respiratory pathogen, gastrointestinal pathogen, sexually transmitted infections, human papillomavirus, tuberculosis, sepsis, meningitis, and pathogen. The company was founded by Jong-Yoon Cheon on September 16, 2000 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company